{"id":"W2014046273","doi":"10.1097/jcp.0000000000000192","title":"A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone to Counteract Antipsychotic-Associated Weight Gain","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Psychopharmacology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Genentech; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; Pfizer; National Institutes of Health; H. Lundbeck A/S; Yale University; Eli Lilly and Company","keywords":"Weight gain; Schizoaffective disorder; Medicine; Naltrexone; Antipsychotic; Overweight; Placebo; Schizophrenia (object-oriented programming); Weight loss; Population; Overeating; Randomized controlled trial; Internal medicine; Psychiatry; Psychosis; Body mass index; Obesity; Opioid; Body weight","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002044799,0.00159832,0.002887533,0.0007939746,0.0008218549,0.0008014487,0.001115635,0.001830233,0.006895494],"category_scores_gemma":[0.002645301,0.00108805,0.001231653,0.0004777275,0.002165517,0.001281392,0.0005434681,0.002434768,0.0008971441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006104695,"about_ca_system_score_gemma":0.001840285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001212286,"about_ca_topic_score_gemma":0.003127093,"domain_scores_codex":[0.9991709,0.0004263695,0.00008806104,0.0001224389,0.00006510258,0.0001271702],"domain_scores_gemma":[0.998203,0.0006081159,0.0003130692,0.0001998296,0.0001362352,0.0005396398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9589865,0.02820284,0.0003068247,0.0002611747,0.000297421,0.0000357464,0.00005038171,0.0001212992,0.004206526,0.00007013846,0.0002337349,0.007227351],"study_design_scores_gemma":[0.8412038,0.1568537,0.0009450621,0.000009767028,0.0001233399,0.0000138051,0.00002008518,0.0001738836,0.0003936212,0.00005613985,0.0001961044,0.00001071678],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987334,0.000945486,0.0006741738,0.0003388251,0.0004772083,0.008584325,0.0006390496,0.0001040782,0.0009030084],"genre_scores_gemma":[0.9773816,0.001625107,0.003559893,0.0007058264,0.0004755372,0.01229945,0.000616791,0.00002377069,0.003312086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006895494,"threshold_uncertainty_score":0.02306771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09343165729162792,"score_gpt":0.4608440513090553,"score_spread":0.3674123940174273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}